'Mitocans' an alternative strategy for cancer treatment

Prijzen vanaf
49,80

Uitgelicht

VERGELIJK ALLE AANBIEDERS (2)

Beschrijving

Bol Cancer is the second leading cause of death in the world. The available treatments have a number of limitations, such as side effects and low efficiency. In the search for new treatments, mitochondria have been highlighted as a promising target for cancer treatment due to the existence of an important relationship between mitochondrial dysfunction and tumourigenesis. Thus, an increase in the number of studies has been observed in recent years, with interest in compounds with action on mitochondrial targets ('mitocans') as an alternative for the treatment of cancer. The aim of this narrative review was to describe the advances in cancer therapy with the emergence of mitochondrial drugs.

Vergelijk aanbieders (2)

Shop
Prijs
Verzendkosten
Totale prijs
49,80
Gratis
49,80
Naar shop
Gratis Shipping Costs
49,99
Gratis
49,99
Naar shop
Gratis Shipping Costs
Beschrijving (2)
Bol

Cancer is the second leading cause of death in the world. The available treatments have a number of limitations, such as side effects and low efficiency. In the search for new treatments, mitochondria have been highlighted as a promising target for cancer treatment due to the existence of an important relationship between mitochondrial dysfunction and tumourigenesis. Thus, an increase in the number of studies has been observed in recent years, with interest in compounds with action on mitochondrial targets ('mitocans') as an alternative for the treatment of cancer. The aim of this narrative review was to describe the advances in cancer therapy with the emergence of mitochondrial drugs.

Amazon

Pages: 88, Paperback, Our Knowledge Publishing


Productspecificaties

Merk Our Knowledge Publishing
EAN
  • 9786203921717
Maat


Prijshistorie

* Prijshistorie bevat geen data van Amazon.

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
49,80
Naar shop